Squamous-cell carcinoma of the tongue following therapy of rheumatoid arthritis with abatacept

KEY CLINICAL MESSAGE: A patient affected by rheumatoid arthritis developed a squamous-cell carcinoma probably due to abatacept, according to Naranjo algorithm. The case describes this adverse reaction for the first time and highlights the need for additional studies to establish the long-term risk p...

Descripción completa

Detalles Bibliográficos
Autores principales: Deidda, Arianna, Pisanu, Claudia, Garau, Donatella, Longu, Maria Giovanna, Moretti, Mario Domenico Luigi, Sanna, Maria Elena, Moretti, Grazia Maria Rita, Stochino, Maria Erminia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2014
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184594/
https://www.ncbi.nlm.nih.gov/pubmed/25356250
http://dx.doi.org/10.1002/ccr3.56
Descripción
Sumario:KEY CLINICAL MESSAGE: A patient affected by rheumatoid arthritis developed a squamous-cell carcinoma probably due to abatacept, according to Naranjo algorithm. The case describes this adverse reaction for the first time and highlights the need for additional studies to establish the long-term risk profile of abatacept.

Ejemplares similares